MLH1 promoter methylation is an alternative marker to the BRAF c.1799T>A variant to exclude sporadic MMR deficient patients with CRC from germline testing and has superior specificity for LS detection (Pérez‐Carbonell et al., 2010). Here, BRAF is linked to colorectal carcinoma.